Market Research Logo

Global Overactive Bladder Treatment Market Research Report 2017

Global Overactive Bladder Treatment Market Research Report 2017

This report studies Overactive Bladder Treatment in Global market, especially in North America, Europe, China, Japan, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson

Market Segment by Regions, this report splits Global into several key Regions, with consumption, revenue, market share and growth rate of Overactive Bladder Treatment in these regions, from 2012 to 2022 (forecast), like
North America
China
Europe
Japan
RoW

Split by Product Types, with revenue market share and growth rate of each type, can be divided into
Anticholinergics
Mirabegron
Botox

Split by applications, this report focuses on consumption, market share and growth rate of Overactive Bladder Treatment in each application, can be divided into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder


1 Overactive Bladder Treatment Market Overview
1.1 Product Overview and Scope of Overactive Bladder Treatment
1.2 Overactive Bladder Treatment Segment by Types
1.2.1 Global Market Share of Overactive Bladder Treatment by Types
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.3 Overactive Bladder Treatment Segment by Applications
1.3.1 Overactive Bladder Treatment Market Share by Applications
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Global Overactive Bladder Treatment Market by Regions (2012-2022)
1.4.1 Global Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2022)
1.4.2 North America Overactive Bladder Treatment Status and Prospect (2012-2022)
1.4.3 Europe Overactive Bladder Treatment Status and Prospect (2012-2022)
1.4.4 Japan Overactive Bladder Treatment Status and Prospect (2012-2022)
1.4.5 China Overactive Bladder Treatment Status and Prospect (2012-2022)
1.4.6 RoW Overactive Bladder Treatment Status and Prospect (2012-2022)
1.5 Global Overactive Bladder Treatment Market Size (2012-2022)
2 Global Overactive Bladder Treatment Market Competition by Manufacturers/Brand
2.1 Global Overactive Bladder Treatment Revenue (M USD) and Share by Manufacturers (2012-2017)
2.2 Global Overactive Bladder Treatment Gross Margin by Manufacturers (2012-2017)
3 Global Overactive Bladder Treatment Revenue (M USD) by Regions (2012-2017)
3.1 Global Overactive Bladder Treatment Revenue (M USD) and Market Share (%) by Regions (2012-2017)
3.2 Global Overactive Bladder Treatment Revenue (M USD) and Gross Margin (%) (2012-2017)
3.3 North America Overactive Bladder Treatment Revenue (M USD) and Gross Margin (%) (2012-2017)
3.4 Europe Overactive Bladder Treatment Revenue (M USD) and Gross Margin (%) (2012-2017)
3.5 Japan Overactive Bladder Treatment Revenue (M USD) and Gross Margin (2012-2017)
3.6 China Overactive Bladder Treatment Revenue (M USD) and Gross Margin (%) (2012-2017)
3.7 RoW Overactive Bladder Treatment Revenue (M USD) and Gross Margin (%) (2012-2017)
4 Global Overactive Bladder Treatment Revenue Trend by Types
4.1 Global Overactive Bladder Treatment Revenue (M USD) and Market Share (%) by Types (2012-2017)
4.2 Global Overactive Bladder Treatment Revenue (M USD) and Growth Rate by Type (2012-2017)
5 Global Overactive Bladder Treatment Revenue Trend by Applications
5.1 Global Overactive Bladder Treatment Revenue (M USD) and Market Share (%) by Applications (2012-2017)
5.2 Global Overactive Bladder Treatment Revenue (M USD) and Growth Rate by Applications (2012-2017)
6 Global Overactive Bladder Treatment Market Forecast by Types and Applications (2017-2022)
6.1 Global Overactive Bladder Treatment Revenue Forecast by Type (2017-2022)
6.2 Global Overactive Bladder Treatment Revenue Forecast by Application (2017-2022)
7 Analysis of Overactive Bladder Treatment Industry Key Manufacturers
7.1 Astellas Pharma
7.1.1 Company Profile
7.1.2 Product Information
7.1.3 Revenue, Cost and Gross Margin
7.2 Allergan
7.2.1 Company Profile
7.2.2 Product Information
7.2.3 Revenue, Cost and Gross Margin
7.3 Pfizer
7.3.1 Company Profile
7.3.2 Product Information
7.3.3 Revenue, Cost and Gross Margin
7.4 Teva Pharmaceutical (Activas)
7.4.1 Company Profile
7.4.2 Product Information
7.4.3 Revenue, Cost and Gross Margin
7.5 Johnson & Johnson
7.5.1 Company Profile
7.5.2 Product Information
7.5.3 Revenue, Cost and Gross Margin
8 Overactive Bladder Treatment Drug Manufacturing Cost Analysis
8.1 Overactive Bladder Treatment Drug Raw Materials Analysis
8.2 Overactive Bladder Treatment Drug R&D Cost Analysis
8.2.1 Clinical Phase Costs
8.2.2 Capitalized Costs
8.3 Proportion of Manufacturing Cost Structure
8.3.1 Raw Materials
8.3.2 Labor Cost
8.3.3 Manufacturing Expenses
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Overactive Bladder Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Overactive Bladder Treatment Market Forecast by Regions (2017-2022)
12.1 Global Overactive Bladder Treatment Revenue (M USD), Revenue (M USD) Forecast (2017-2022)
12.2 Global Overactive Bladder Treatment Revenue (M USD) Forecast by Regions (2017-2022)
12.2.1 North America Overactive Bladder Treatment Revenue Forecast (2017-2022)
12.2.2 Europe Overactive Bladder Treatment Revenue (M USD) and Revenue Forecast (2017-2022)
12.2.3 Japan Overactive Bladder Treatment Revenue (M USD) and Revenue Forecast (2017-2022)
12.2.4 China Overactive Bladder Treatment Revenue (M USD) and Revenue Forecast (2017-2022)
12.2.5 RoW Overactive Bladder Treatment Revenue (M USD) and Revenue Forecast (2017-2022)
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Tables and Figures
Figure Picture of Overactive Bladder Treatment
Figure Global Overactive Bladder Treatment Revenue (M USD) Comparison by Types (Product Category) (2012-2022)
Figure Global Overactive Bladder Treatment Revenue Market Share (%) by Types in 2016
Figure Product Picture of Anticholinergics
Figure Product Picture of Mirabegron
Figure Product Picture of Botox
Figure Global Overactive Bladder Treatment Revenue (M USD) Comparison by Applications (2012-2022)
Figure Global Overactive Bladder Treatment Revenue Market Share (%) by Applications in 2016
Figure Global Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2022)
Figure North America Overactive Bladder Treatment Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Europe Overactive Bladder Treatment Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Japan Overactive Bladder Treatment Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure China Overactive Bladder Treatment Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure RoW Overactive Bladder Treatment Revenue (M USD) and Growth Rate (%) (2012-2022)
Figure Global Overactive Bladder Treatment Revenue (M USD) Status and Outlook (2012-2022)
Table Global Overactive Bladder Treatment Revenue (M USD) of Key Manufacturers (2012-2017)
Table Global Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers (2012-2017)
Figure 2012 Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers
Figure 2013 Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers
Figure 2014 Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers
Figure 2015 Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers
Figure 2016 Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers
Figure 2017 Overactive Bladder Treatment Revenue Market Share (%) by Manufacturers
Table Global Overactive Bladder Treatment Gross Margin by Manufacturers (2012-2017)
Figure 2016 Global Overactive Bladder Treatment Gross Margin by Manufacturers
Table Global Overactive Bladder Treatment Revenue (M USD) by Regions (2012-2017)
Table Global Overactive Bladder Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure Global Overactive Bladder Treatment Revenue Market Share (%) by Regions (2012-2017)
Figure 2012 Global Overactive Bladder Treatment Revenue Market Share (%) by Regions
Figure 2013 Global Overactive Bladder Treatment Revenue Market Share (%) by Regions
Figure 2014 Global Overactive Bladder Treatment Revenue Market Share (%) by Regions
Figure 2015 Global Overactive Bladder Treatment Revenue Market Share (%) by Regions
Figure 2016 Global Overactive Bladder Treatment Revenue Market Share (%) by Regions
Figure 2017 Global Overactive Bladder Treatment Revenue Market Share (%) by Regions
Figure Global Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2017)
Figure North America Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2017)
Figure Europe Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2017)
Figure Japan Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2017)
Figure China Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2017)
Figure RoW Overactive Bladder Treatment Revenue Market Size Comparison by Regions (2012-2017)
Table Global Overactive Bladder Treatment Revenue (M USD) by Types (2012-2017)
Table Global Overactive Bladder Treatment Revenue Market Share (%) by Types (2012-2017)
Figure Revenue Market Share (%) of Overactive Bladder Treatment by Types (2012-2017)
Figure 2012 Revenue Market Share (%) of Overactive Bladder Treatment by Types
Figure 2013 Revenue Market Share (%) of Overactive Bladder Treatment by Types
Figure 2014 Revenue Market Share (%) of Overactive Bladder Treatment by Types
Figure 2015 Revenue Market Share (%) of Overactive Bladder Treatment by Types
Figure 2016 Revenue Market Share (%) of Overactive Bladder Treatment by Types
Figure 2017 Revenue Market Share (%) of Overactive Bladder Treatment by Types
Figure Global Anticholinergics Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2012-2017)
Figure Global Mirabegron Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2014-2017)
Figure Global Botox Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2012-2017)
Table Global Overactive Bladder Treatment Revenue (M USD) by Applications (2012-2017)
Table Global Overactive Bladder Treatment Revenue Market Share (%) by Applications (2012-2017)
Figure Revenue Market Share (%) of Overactive Bladder Treatment by Applications (2012-2017)
Figure 2012 Revenue Market Share (%) of Overactive Bladder Treatment by Applications
Figure 2013 Revenue Market Share (%) of Overactive Bladder Treatment by Applications
Figure 2014 Revenue Market Share (%) of Overactive Bladder Treatment by Applications
Figure 2015 Revenue Market Share (%) of Overactive Bladder Treatment by Applications
Figure 2016 Revenue Market Share (%) of Overactive Bladder Treatment by Applications
Figure 2017 Revenue Market Share (%) of Overactive Bladder Treatment by Applications
Figure Global Idiopathic Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2012-2017)
Figure Global Neurogenic Overactive Bladder Treatment Revenue (M USD) and Growth Rate (2014-2017)
Table Global Overactive Bladder Treatment Revenue Forecast by Type (2017-2022)
Figure Global Overactive Bladder Treatment Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global Overactive Bladder Treatment Revenue Forecast by Application (2017-2022)
Figure Global Overactive Bladder Treatment Revenue Market Share by Application (2017-2022)
Table Astellas Pharma Company Profile
Table Overactive Bladder Treatment Information of Astellas Pharma (Vesicare)
Table Overactive Bladder Treatment Information of Astellas Pharma (Betanis / Myrbetriq / BETMIGA)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Astellas Pharma (2012-2017)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Astellas Pharma (2012-2017)
Table Allergan Company Profile
Table Overactive Bladder Treatment Information of Allergan (Botox)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Allergan (2012-2017)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Allergan (2012-2017)
Table Pfizer Company Profile
Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Pfizer (2012-2017)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Pfizer (2012-2017)
Table Teva Pharmaceutical (Activas) Company Profile
Table Overactive Bladder Treatment Information of Teva Pharmaceutical (Oxytrol)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Teva Pharmaceutical (Activas) (2012-2017)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Teva Pharmaceutical (Activas) (2012-2017)
Table Johnson & Johnson Company Profile
Table Overactive Bladder Treatment Information of Johnson & Johnson (Ditropan and Ditropan XL)
Table Overactive Bladder Treatment Revenue (M USD), Cost (M USD) and Gross Margin of Johnson & Johnson (2012-2017)
Figure Overactive Bladder Treatment Revenue (M USD) and Market Share of Johnson & Johnson (2012-2017)
Figure Typical Phases from Research to the Market for a Drug Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Overactive Bladder Treatment Drug
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%)
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016
Figure 2016 Global Manufacturing Competitiveness Index Rankings by Country
Figure US Nonfarm Unit Labor Cost 2014-2016
Figure United States Average Hourly Wages (USD/H) 2016-2017
Figure China Labor Cost Index 2014-2016
Figure China Average Yearly Wages 2006-2016
Figure Euro Area Labor Cost 2014-2016
Figure Japan Overview of Average Monthly Wages 2012-2017 (JPY Thousand/Month)
Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%)
Table 2016 Global Electricity Price of Industry (USD/KWh) by Country
Figure Overactive Bladder Treatment Industrial Chain Analysis
Table Major Buyers of Overactive Bladder Treatment
Table Distributors/Traders List
Figure Global GDP Growth Rate for 2016
Figure Malaysia GDP 2006-2016 (Billion USD)
Figure Brunei GDP 2006-2016 (Billion USD)
Figure Brazil GDP 2006-2016 (Billion USD)
Figure Brazil CPI Change 2016-2017
Figure Mexico GDP 2006-2016 (Billion USD)
Figure Mexico CPI Change 2012-2016
Figure USA GDP 2006-2016 (Billion USD)
Figure USA CPI Change 2016-2017
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016 86

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report